2026 QI and Tech Update
.
Nirav Shah
Agenda
Progress Platform upgrades Plans
Disclosures
No personal financial, consulting, or contractual
relationships with any vendor
Projects sponsored by contracts / grants paid to University of
Michigan:
Blue Cross Blue Shield Michigan (BCBSM)
Patient Centered Outcomes Research Institute (PCORI)
National Institutes of Health (NIH)
Chiesi
GE Healthcare
Thank You
Measure Reviewers
Patrick Henson
Vanderbilt University
GLU-09, GLU 10, GLU 11
Management of
Hyperglycemia
Beth Duggan
University of Alabama
GLU 12 and GLU 13 –
Management of
Hypoglycemia
Morgan Brown
Boston Children's
PAIN 01 Peds
Lauren Madoff
Boston Children's
TEMP 04 Peds
Clark Fisher
Yale University
Opioid Equivalency
Brandon Togioka
Oregon Health Sciences
University
ABX 01 OB – Antibiotic
Timing for Cesarean
Delivery
Jonathan Paul
Columbia University
Medical Center
BP 01, BP 03, BP 06 Low
MAP Prevention
Tariq Esmail
University of Toronto
PONV 03 – Postoperative
Nausea and Vomiting
Measure Reviewers
Measure Reviewers
Joe McComb
Temple University
PUL 01 – Protective Tidal
Volume, 10 mL/kg PBW
Ketan Chopra
Henry Ford Health
PUL-03 – Administration of
PEEP
Mike Mathis
University of Michigan
AKI-01 – Acute Kidney
Injury
Alvin Stewart
University of Arkansas
TOC 02 and TOC 03 –
Postoperative Transfer of
Care to PACU and ICU
Teshi Kaushik
University of Alabama
BP 04 OB – Hypotension
after neuraxial placement
for Cesarean Delivery
Rob Schonberger
Yale University
GLU 07 Cardiac
Management of
Hyperglycemia
Josh Billings
Vanderbilt University
GLU 06 Cardiac
GLU 08 Cardiac
Management of
Hyperglycemia
Measure Reviewers
Subcommittee Leadership
Allison Janda
Morgan Brown
Brandon Togioka
Meridith Wade
Sharon Reale Eva Lu-Boettcher Ashanpreet Grewal
Kate Buehler
Progress
110 Health System and Hospital Dashboards
28 States, 3 Countries, 1 Coordinating Center
Provider Feedback Growth
MOCA Participants
New Measures
AKI 03 Peds
TRAN 06 Peds
NCR 01 OB
UDP 01 OB
TRAN 05 Cards
GLU 14 Cards
GLU 17
SUS 09
Making a Difference?
SUS 02 – Efficient FGF and
Anesthetic Agent Choice
23.6%
23.2%
23.5%
27.5%
30.7%
34.5%
39.9%
47.7%
57.0%
62.6%
65.4%
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
70.0%
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Score
Year
Efficient FGF and Agent Choice
GLU 11 – Treatment of Hyperglycemia (> 180 mg/dL)
with insulin from preop through PACU
37.6%
34.3%
34.7%
39.6%
40.5%
42.6%
43.6%
43.9%
47.1%
48.7%
50.4%
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Score
Year
Treatment of Perioperative Hyperglycemia
State of Michigan in Blue
Rates of Postoperative Nausea and
Vomiting
10.7%
11.1%
11.2%
11.3%
11.4%
11.2%
0.0%
2.0%
4.0%
6.0%
8.0%
10.0%
12.0%
14.0%
2021 2022 2023 2024 2025 2026
Inverse Score
Year
Postoperative Nausea or Vomiting
Raising the Bar
NMB 01 (Checking
Train of Fours)
to
NMB 05 (Use of
Quantitative
Monitoring)
GLU 01 (Management
of Intraoperative
Hyperglycemia > 200
mg/dL)
to
GLU 16 (Treatment of
Interoperative
Hyperglycemia > 180
mg/dL
SUS 01
(FGF < 3L / min)
to
SUS 08
(FGF < 1L/min)
Upgrades
MPOG Data Library consolidates our data dictionaries
• Concept Browser +
Phenotype Browser
+ Measure Browser
(DMS)
• Requires login to
view
• Tiered access
based on need /
role
QI Reporting Tool becoming MPOG Reporting
Plans
Acute Care Episode Data
Operating Room
Vitals / Monitor Data
Medications
Hospital
Admission
Hospital
Discharge
Laboratory Data
Administrative Data
1yr Prior to
Case
1yr After Case
Structured Documentation
Admission, Discharge and Transfer
Patient Attributes
Procedure, Progress and Discharge Notes
Other things we are working on...
Using LLMs to automate
"collation" mapping
Major Infrastructure
upgrades
Redesign Provider
Feedback Emails
Thank you
